We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-2.45%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$364M
AUM Growth
-$19.7M
Cap. Flow
-$6.77M
Cap. Flow %
-1.86%
Top 10 Hldgs %
44.42%
Holding
83
New
22
Increased
23
Reduced
12
Closed
26

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$17.9M
2
ICLR icon
Icon
ICLR
+$17.1M
3
TMO icon
Thermo Fisher Scientific
TMO
+$14M
4
THC icon
Tenet Healthcare
THC
+$13.5M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$10.6M

Top Sells

Rank Stock Value
1
KIDS icon
OrthoPediatrics
KIDS
+$19.3M
2
AHCO icon
AdaptHealth
AHCO
+$14.7M
3
SNY icon
Sanofi
SNY
+$13.5M
4
BDX icon
Becton Dickinson
BDX
+$13.2M
5
CVS icon
CVS Health
CVS
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 80.17%
2 Industrials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
76
Tarsus Pharmaceuticals
TARS
$2.65B
– –
-14,143
Closed -$456K
ZTS icon
77
Zoetis
ZTS
$31.4B
– –
-17,668
Closed -$2.78M
NVRO
78
DELISTED
NEVRO CORP.
NVRO
– –
-6,442
Closed -$899K
SEEL
79
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-159
Closed -$3.05M
APTO
80
DELISTED
Aptose Biosciences, Inc.
APTO
– –
-1,150
Closed -$3.09M
LBPH
81
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
– –
-16,327
Closed -$267K
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Endurant Capital Management held 83 positions worth $364M, down 5.1% from $384M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Endurant Capital Management's Q2 2021 filing shows 22 new, 23 increased, 12 reduced and 26 closed positions. Its largest new stake was Cigna: 71,856 shares worth $17M. The largest sale was OrthoPediatrics, an estimated $19.3M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 86% a quarter earlier, followed by Industrials.

  • Endurant Capital Management's largest Q2 2021 buy was Cigna: 71,856 shares worth $17M.
  • Endurant Capital Management added most to R1 RCM Inc. Common Stock in Q2 2021, an estimated $10.6M increase.
  • Endurant Capital Management's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $8.66M.
  • Endurant Capital Management fully exited OrthoPediatrics in Q2 2021, selling an estimated $19.3M.
  • Endurant Capital Management's ten largest holdings make up 44% of its $364M portfolio in Q2 2021.
  • Endurant Capital Management opened 22 new positions and closed 26 in Q2 2021.
  • Endurant Capital Management's portfolio value fell 5.1% quarter-over-quarter to $364M.

Based on Endurant Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.